Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Fadhela Bouafia"'
Autor:
Pierre Sesques, Lionel Karlin, Emmanuel Massy, Alizée Maarek, Guillaume Aussedat, Anne Lazareth, Camille Golfier, Fadhela Bouafia-Sauvy, Helene Lequeu, Dana Ghergus, Violaine Safar, Emmanuelle Ferrant, Emmanuel Bachy, Hervé Ghesquières, Cyrille B. Confavreux, Delphine Demangel, Emeline Perrial, Charles Dumontet
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundIn spite of spectacular advances in the treatment of multiple myeloma, a majority of patients will die from this disease or related complications. While a great amount of focus has been dedicated to the development of novel therapies, littl
Externí odkaz:
https://doaj.org/article/4a125c6c53de4fb0b5064a8ef7afa57d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphoma
Autor:
Estelle Bourbon, Pierre Sesques, Morgane Gossez, Jérémie Tordo, Emmanuelle Ferrant, Violaine Safar, Florent Wallet, Guillaume Aussedat, Alizée Maarek, Fadhela Bouafia, Lionel Karlin, Dana Ghergus, Camille Golfier, Hélène Lequeu, Anne Lazareth, Vérane Schwiertz, Sébastien Viel, Maryam Idlhaj, Hervé Ghesquières, Guillaume Monneret, Emmanuel Bachy, Fabienne Venet
Publikováno v:
Blood Advances
Blood Advances, 2023, 7 (5), pp.744-755. ⟨10.1182/bloodadvances.2021006563⟩
Blood Advances, 2023, 7 (5), pp.744-755. ⟨10.1182/bloodadvances.2021006563⟩
Despite their unprecedented success in relapsed/refractory (R/R) large B-cell lymphoma (LBCL), anti-CD19 CAR T cells are associated with significant toxicity, and more than half of patients relapse. As monocytes emerged as key players in CAR therapy,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6334914490903dc8f9f76f2077aa2fa6
https://doi.org/10.1182/bloodadvances.2021006563
https://doi.org/10.1182/bloodadvances.2021006563
Autor:
Zofia Gross, Maryam Idlhaj, Lionel Karlin, Arnaud Friggeri, Anne Lazareth, Camille Golfier, Helene Lequeu, Fadhela Bouafia Sauvy, Pierre Sesques, Violaine Safar, Emmanuelle Ferrant, Dana Ghergus, Alizee Maarek, Guillaume Aussedat, Gilles Salles, Emmanuel Bachy, Florent Wallet, Herve Ghesquieres
Publikováno v:
Blood. 140:13099-13101
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f91cc2be521f451f986a8ee71f78525
https://doi.org/10.1182/blood-2022-165911
https://doi.org/10.1182/blood-2022-165911
Autor:
Clara Sortais, Stéphanie Cordeil, Estelle Bourbon, Maryam Idlhaj, Emmanuelle Ferrant, Violaine Safar, Camille Golfier, Anne Lazareth, Fadhela Bouafia-Sauvy, Jérémie Tordo, Hervé Ghesquières, Pierre Sesques, Emmanuel Bachy
Publikováno v:
Leukemialymphoma.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d06d6d8a09407973a2c56d4852191c9
https://pubmed.ncbi.nlm.nih.gov/36573418
https://pubmed.ncbi.nlm.nih.gov/36573418
Autor:
Herve Ghesquieres, Emmanuelle Ferrant, Clément Rocher, Violaine Safar, Frédérique Orsini-Piocelle, Claire Mauduit, Pierre Sesques, Delphine Maucort-Boulch, Arthur Dony, Juliette Fontaine, François-Xavier Gros, Anne Lazareth, Lionel Karlin, Cédric Rossi, Gian Matteo Pica, Alexandra Traverse-Glehen, Camille Golfier, Estelle Bourbon, Fadhela Bouafia, Clémentine Sarkozy, Marie Parrens, Emmanuel Bachy, Dana Ghergus
Publikováno v:
Blood Adv
In this retrospective study, we report 70 cases of Epstein-Barr virus (EBV)+ diffuse large B-cell lymphoma not otherwise specified (DLBCL-NOS) among 1696 DLBCL-NOS cases diagnosed between 2006 and 2019 (prevalence of 4.1%). At diagnosis, median age w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bae7bce6eb37b7d94e1927549d050d95
https://doi.org/10.1182/bloodadvances.2021004515
https://doi.org/10.1182/bloodadvances.2021004515
Autor:
Caroline LE Lan, Aurelien Belot, Camille Golfier, Berenice Audin, Pierre Sesques, Adeline Bernier, Violaine Safar, Alexandra Marquet, Emmanuelle Ferrant, Anne Lazareth, Helene Lequeu, Fadhela Bouafia, Lionel Karlin, Dana Ghergus, Alizee Maarek, Guillaume Aussedat, Maryam Idlhaj, Gilles Salles, Fanny Cherblanc, Emmanuel Bachy, Herve Ghesquieres
Publikováno v:
Blood. 140:5210-5211
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b647e36b3ef6ccd294f68333699c6f39
https://doi.org/10.1182/blood-2022-164552
https://doi.org/10.1182/blood-2022-164552
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Violaine Safar, Emmanuelle Nicolas-Virelizier, Lionel Karlin, Alexandra Traverse-Glehen, Catherine Chassagne-Clément, Gabriel Brisou, Anne Lazareth, Fadhela Bouafia, Gabriel Antherieu, Youenn Drouet, François Ducray, David Meyronet, Emmanuel Bachy, Emmanuelle Ferrant, Hervé Ghesquières, Edith Julia, Pierre Sesques, Gilles Salles, Camille Golfier, Marie-Charlotte Laude, Dana Ghergus, Helene Lequeu, Philippe Rey
Publikováno v:
Blood. 136:43-45
Background: Diagnostic-to-treatment interval (DTI) was recently described as a strong prognostic factor for newly diagnosed systemic diffuse large B-cell lymphoma patients (DLBCL) with an improvement of event-free survival (EFS) for patients with a l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6fcc61c40ce6de924a055bbbcccc9dc6
https://doi.org/10.1182/blood-2020-138789
https://doi.org/10.1182/blood-2020-138789
Autor:
Pierre Sujobert, Pierre Sesques, Doriane Cavalieri, Violaine Safar, Emmanuel Bachy, Fadhela Bouafia, Vérane Schwiertz, Jeremie Tordo, Olivier Hequet, Florence Ader, Gabriel Brisou, Fabienne Venet, Yazid Arkam, Lionel Karlin, Catherine Rioufol, Herve Ghesquieres, Frederic Peyrade, Helene Lequeu, Florent Wallet, Valérie Mialou, Adrien Chauchet, Alexandra Traverse Glehen, Anthony Dhomps, Marlène Vercasson, Anne Lazareth, Marion Choquet, Sébastien Viel, Dana Ghergus, Emmanuelle Nicolas-Virelizier, Gilles Salles, Carole Hospital-Gustem, Emmanuelle Ferrant, Camille Golfier, Silvana Novelli, Florence Ranchon, Perrine Devic
Publikováno v:
American journal of hematologyREFERENCES. 95(11)
Two autologous anti-CD19 chimeric antigen receptors (CAR) T cells (axicabtagene ciloleucel [axi-cel] and tisagenlecleucel [tisa-cel]) are commercially approved in Europe for relapsed/refractory (R/R) diffuse large B cell lymphoma (DLBCL). We performe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f99cf3c88efac612c50fc01e60c43f8
https://pubmed.ncbi.nlm.nih.gov/32744738
https://pubmed.ncbi.nlm.nih.gov/32744738